Source: ERJ Open Res, 6 (1) 00259-2019; 10.1183/23120541.00259-2019
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Koh Nakata, Tatsuki Sugi, Keiko Kuroda, Kazutaka Yoshizawa, Toshinori Takada, Ryushi Tazawa, Takahiro Ueda, Ami Aoki, Mitsuhiro Abe, Koichiro Tatsumi, Ryosuke Eda, Shotaro Kondoh, Konosuke Morimoto, Takeshi Tanaka, Etsuro Yamaguchi, Ayumu Takahashi, Miku Oda, Haruyuki Ishii, Shinyu Izumi, Haruhito Sugiyama, Atsushi Nakagawa, Keisuke Tomii, Masaru Suzuki, Satoshi Konno, Shinya Ohkouchi, Taizou Hirano, Tomohiro Handa, Toyohiro Hirai, Yoshikazu Inoue, Toru Arai, Katsuaki Asakawa, Takuro Sakagami, Takahiro Tanaka, Ayako Mikami, Nobutaka Kitamura. Validation of a new serum granulocyte–macrophage colony-stimulating factor autoantibody testing kit. ERJ Open Res, 6 (1) 00259-2019; 10.1183/23120541.00259-2019

Member's Comments

No comment yet.

Related content which might interest you: Expression and secretion of macrophage colony-stimulating factor by peripheral blood stem cell-derived human basophils Source: Eur Respir J 2006; 28: Suppl. 50, 746s Year: 2006 A mouse GM-CSF receptor antibody attenuates neutrophilia in mice exposed to cigarette smoke Source: Eur Respir J 2011; 38: 285-294 Year: 2011 Granulocyte colony-stimulating factor enhances the anticancer effects of cisplatin against lung cancer by promoting angiogenesis Source: Annual Congress 2008 - Therapy of thoracic tumours Year: 2008 Aerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosis Source: Eur Respir J 2006; 27: 585-593 Year: 2006 Efficacy of aerosolized granulocyte-macrophage colony stimulating factor (GM-CSF) in a Japanese female patient with pulmonary alveolar proteinosis (PAP) Source: Eur Respir J 2001; 18: Suppl. 33, 221s Year: 2001 Association of genetic variations in the CSF2 and CSF3 genes with lung function in smoking-induced COPD Source: Eur Respir J 2008; 32: 25-34 Year: 2008 Plasmapheresis for treatment of pulmonary alveolar proteinosis Source: Eur Respir J 2009; 33: 1220-1222 Year: 2009 Granulocyte-macrophage colony-stimulating factor is activated by cytosolic phospholipase a2 group IV α in human lung cells Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases Year: 2009 Inhaled granulocyte–macrophage colony-stimulating factor for Mycobacterium abscessus in cystic fibrosis Source: Eur Respir J, 51 (4) 1702127; 10.1183/13993003.02127-2017 Year: 2018 Evaluation levels of pro-inflammatory cytokines tumour necrosis factor (TNF)-alpha and interleukin (IL) 1-beta in small cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 233s Year: 2001 High serum granulocyte-colony stimulating factor characterises neutrophilic COPD exacerbations associated with dysbiosis Source: ERJ Open Res, 7 (3) 00836-2020; 10.1183/23120541.00836-2020 Year: 2021 Anti-inflammatory activity of β2-agonists in primary lung epithelial cells is independent of glucocorticoid receptor Source: Eur Respir J 2007; 30: 848-856 Year: 2007 Granulocyte-macrophage colony stimulating factor inhalation therapy as a treatment for pulmonary alveolar proteinosis Source: Eur Respir J 2003; 22: Suppl. 45, 377s Year: 2003 Increased expression of angiogenic growth factor stromal cell derived factor-1 (SDF-1/CXCL12) in pleural fluid of patients with lung cancer: preliminary results Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008 Does tumour necrosis factor-alpha (TNF-alpha) induced by lipopolysaccharide have a positive feedback effect on the up-regulation of interleukin-8 (IL-8) messenger RNA by monocytes from COPD patients? Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013 The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement Source: Eur Respir J 2010; 36: 1185-1206 Year: 2010 Transforming growth factor beta (TGF-ß) pathway activation by IPF fibroblast-derived soluble factors is mediated by IL-6 trans-signaling Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 Levels of plasma tumour necrosis factor and soluble tumour necrosis factor receptor in patients with COPD and its relation to glucocorticoid receptor levels Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 C-reactive protein induces the expression of tissue factor and interleukin-8 in the lung Source: Eur Respir J 2003; 22: Suppl. 45, 265s Year: 2003